WO1998027980A2
(en)
*
|
1996-12-20 |
1998-07-02 |
Takeda Chemical Industries, Ltd. |
Method of producing a sustained-release preparation
|
US6191107B1
(en)
*
|
1997-09-26 |
2001-02-20 |
Takeda Chemical Industries, Ltd. |
Complex of human growth hormone and zinc
|
NZ525914A
(en)
|
1998-03-10 |
2004-03-26 |
Genentech Inc |
Novel polypeptides and nucleic acids encoding the same
|
EP3112468A1
(en)
|
1998-05-15 |
2017-01-04 |
Genentech, Inc. |
Il-17 homologous polypeptides and therapeutic uses thereof
|
EP1076703B2
(en)
|
1998-05-15 |
2010-12-15 |
Genentech, Inc. |
Therapeutic uses of il-17 homologous polypeptides
|
US20020172678A1
(en)
|
2000-06-23 |
2002-11-21 |
Napoleone Ferrara |
EG-VEGF nucleic acids and polypeptides and methods of use
|
DE60043322D1
(en)
|
1999-06-15 |
2009-12-24 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids for their coding
|
CA2490853A1
(en)
|
1999-12-01 |
2001-06-07 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
EP1897945B1
(en)
|
1999-12-23 |
2012-01-18 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
CN1425066B
(en)
|
2000-01-13 |
2010-05-26 |
杰南技术公司 |
Novel stra6 polypeptides
|
KR100890125B1
(en)
|
2000-02-24 |
2009-03-24 |
일라이 릴리 앤드 캄파니 |
Non-aqueous injectable formulations for extended release of somatotropin
|
US6740520B2
(en)
|
2000-03-21 |
2004-05-25 |
Genentech, Inc. |
Cytokine receptor and nucleic acids encoding the same
|
CA2402191C
(en)
|
2000-03-24 |
2012-03-13 |
Genentech, Inc. |
Use of insulin for the treatment of cartilagenous disorders
|
AU6531101A
(en)
|
2000-06-02 |
2001-12-17 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
WO2002000261A2
(en)
|
2000-06-26 |
2002-01-03 |
Monsanto Technology Llc |
Surfactant-containing formulations for extended release of somatotropin
|
US6664234B1
(en)
|
2000-06-30 |
2003-12-16 |
Monsanto Technology Llc |
Non-aqueous injectable formulation preparation with pH adjusted for extended release of somatotropin
|
CA2418960A1
(en)
|
2000-08-07 |
2002-02-14 |
Inhale Therapeutic Systems, Inc. |
Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
|
ATE412009T1
(en)
|
2000-08-24 |
2008-11-15 |
Genentech Inc |
METHOD FOR INHIBITING IL-22 INDUCED PAP1
|
EP1944317A3
(en)
|
2000-09-01 |
2008-09-17 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US6673580B2
(en)
|
2000-10-27 |
2004-01-06 |
Genentech, Inc. |
Identification and modification of immunodominant epitopes in polypeptides
|
US20070160576A1
(en)
|
2001-06-05 |
2007-07-12 |
Genentech, Inc. |
IL-17A/F heterologous polypeptides and therapeutic uses thereof
|
DK1485477T3
(en)
|
2002-02-25 |
2009-08-10 |
Genentech Inc |
New type 1 cytokine receptor GLM-R
|
ES2349779T5
(en)
|
2003-04-04 |
2013-11-26 |
Genentech, Inc. |
Antibody and protein formulations at high concentration
|
DE602004019919D1
(en)
|
2003-06-06 |
2009-04-23 |
Genentech Inc |
MODULATION OF THE INTERACTION BETWEEN HGF BETA CHAIN AND C-MET
|
CA2530284A1
(en)
|
2003-07-08 |
2005-02-03 |
Genentech, Inc. |
Il-17 a/f heterologous polypeptides and therapeutic uses thereof
|
US20050233960A1
(en)
|
2003-12-11 |
2005-10-20 |
Genentech, Inc. |
Methods and compositions for inhibiting c-met dimerization and activation
|
US7481997B1
(en)
|
2004-02-12 |
2009-01-27 |
Montana State University |
Snow mountain virus genome sequence, virus-like particles and methods of use
|
US9845344B2
(en)
|
2004-03-30 |
2017-12-19 |
Hoba Therapeutics Aps |
Therapeutic use of a growth factor, NsG33
|
US7264314B2
(en)
|
2004-10-27 |
2007-09-04 |
Brennan Miles B |
Adrenocorticotropic hormone analogs and related methods
|
US8389469B2
(en)
|
2005-06-06 |
2013-03-05 |
The Rockefeller University |
Bacteriophage lysins for Bacillus anthracis
|
CA2610709A1
(en)
|
2005-06-06 |
2006-12-14 |
Genentech, Inc. |
Transgenic models for different genes and their use for gene characterization
|
EP2322552B1
(en)
|
2005-06-21 |
2016-02-10 |
Xoma (Us) Llc |
IL-1beta binding antibodies and fragments thereof
|
US7582291B2
(en)
|
2005-06-30 |
2009-09-01 |
The Rockefeller University |
Bacteriophage lysins for Enterococcus faecalis, Enterococcus faecium and other bacteria
|
EP1995321A2
(en)
|
2005-08-15 |
2008-11-26 |
Genentech, Inc. |
Gene disruptions, compositions and methods relating thereto
|
EP1917355B1
(en)
|
2005-08-24 |
2010-12-08 |
The Rockefeller University |
Ply-gbs mutant lysins
|
EP1962584A2
(en)
|
2005-11-21 |
2008-09-03 |
Genentech, Inc. |
Novel gene disruptions, compositions and methods relating thereto
|
EP1973942B1
(en)
|
2005-12-22 |
2011-02-09 |
Genentech, Inc. |
Recombinant production of heparin binding proteins
|
AR059300A1
(en)
|
2006-02-02 |
2008-03-26 |
Trimeris Inc |
INHIBITING PEPTIDES OF HIV FUSION WITH IMPROVED BIOLOGICAL PROPERTIES
|
WO2007114979A2
(en)
|
2006-02-17 |
2007-10-11 |
Genentech, Inc. |
Gene disruptons, compositions and methods relating thereto
|
WO2007109376A2
(en)
|
2006-03-23 |
2007-09-27 |
Novartis Ag |
Anti-tumor cell antigen antibody therapeutics
|
US7695928B2
(en)
|
2006-04-10 |
2010-04-13 |
Genentech, Inc. |
Disheveled PDZ modulators
|
WO2008036437A2
(en)
|
2006-04-19 |
2008-03-27 |
Genentech, Inc. |
Novel gene disruptions, compositions and methods relating thereto
|
LT2049148T
(en)
*
|
2006-07-06 |
2016-11-25 |
Daewoong Co., Ltd. |
A stable liquid formulation of human growth hormone
|
CN103405768A
(en)
|
2006-12-20 |
2013-11-27 |
爱克索马技术有限公司 |
Methods for the treatment of IL-1[beta] related diseases
|
CN101361968B
(en)
|
2007-08-06 |
2011-08-03 |
健能隆医药技术(上海)有限公司 |
Use of interleukin-22 in treating fatty liver
|
DK2391650T3
(en)
|
2007-12-20 |
2015-01-12 |
Xoma Us Llc |
Methods of treating gout
|
CN109010254A
(en)
*
|
2008-08-15 |
2018-12-18 |
硬木药品公司 |
It is suitble to the stable solid pharmaceutical preparation of the guanylate cyclase-C receptor agonist polypeptide of oral administration
|
WO2010027404A2
(en)
*
|
2008-09-04 |
2010-03-11 |
Ironwood Pharmaceuticals, Inc. |
Stable solid formulation of therapeutic polypeptides suitable for oral administration
|
WO2011017502A2
(en)
*
|
2009-08-06 |
2011-02-10 |
Ironwood Pharmaceuticals, Inc. |
Linaclotide-containing formulations for oral administration
|
JP6016636B2
(en)
|
2009-10-15 |
2016-10-26 |
ジェネンテック, インコーポレイテッド |
Chimeric fibroblast growth factor with altered receptor specificity
|
WO2011056561A1
(en)
|
2009-10-27 |
2011-05-12 |
Beth Israel Deaconess Medical Center |
Methods and compositions for the generation and use of conformation-specific antibodies
|
NZ600361A
(en)
|
2009-12-21 |
2014-06-27 |
Ambrx Inc |
Modified bovine somatotropin polypeptides and their uses
|
CN102666578A
(en)
|
2009-12-21 |
2012-09-12 |
Ambrx公司 |
Modified porcine somatotropin polypeptides and their uses
|
JP5878477B2
(en)
|
2010-01-15 |
2016-03-08 |
ユニバーシティ オブ メディスン アンド デンティストリー オブ ニュー ジャージー |
Use of vanadium compounds to accelerate bone healing
|
MX340234B
(en)
|
2010-02-17 |
2016-07-01 |
Ironwood Pharmaceuticals Inc |
Treatments for gastrointestinal disorders.
|
JP5937059B2
(en)
|
2010-03-22 |
2016-06-22 |
ジェネンテック, インコーポレイテッド |
Compositions and methods useful for stabilizing protein-containing formulations
|
JP2013525484A
(en)
|
2010-05-03 |
2013-06-20 |
ジェネンテック, インコーポレイテッド |
Compositions and methods useful for reducing the viscosity of protein-containing formulations
|
KR102058307B1
(en)
|
2010-06-24 |
2019-12-20 |
제넨테크, 인크. |
Compositions and methods containing alkylgycosides for stabilizing protein-containing formulations
|
HUE046922T2
(en)
|
2010-08-11 |
2020-03-30 |
Ironwood Pharmaceuticals Inc |
Stable formulations of linaclotide
|
CN102380091A
(en)
|
2010-08-31 |
2012-03-21 |
健能隆医药技术(上海)有限公司 |
Application of interleukin-22 in curing virus hepatitis
|
CN103269708A
(en)
|
2010-10-01 |
2013-08-28 |
Ns基因公司 |
Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
|
WO2012045274A1
(en)
|
2010-10-08 |
2012-04-12 |
Shanghai Kexin Biotech Co., Ltd. |
Moesin modulators and uses thereof
|
KR101631740B1
(en)
|
2010-10-08 |
2016-06-17 |
상하이 켁신 바이오테크 씨오., 엘티디. |
Diagnostic and therapeutic uses of moesin fragments
|
WO2012092539A2
(en)
|
2010-12-31 |
2012-07-05 |
Takeda Pharmaceutical Company Limited |
Antibodies to dll4 and uses thereof
|
WO2012149334A2
(en)
|
2011-04-27 |
2012-11-01 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for the generation and use of conformation-specific antibodies
|
US8877473B2
(en)
*
|
2011-06-02 |
2014-11-04 |
Baxter International Inc. |
Formulations of recombinant furin
|
PL2776055T3
(en)
|
2011-08-17 |
2017-06-30 |
Ironwood Pharmaceuticals, Inc. |
Treatments for gastrointestinal disorders
|
RU2665810C2
(en)
|
2011-10-31 |
2018-09-04 |
Дженентек, Инк. |
Antibody formulations
|
EP3050900A1
(en)
|
2011-12-19 |
2016-08-03 |
Xoma (Us) Llc |
Methods for treating acne
|
US10774132B2
(en)
|
2012-01-09 |
2020-09-15 |
The Scripps Research Instittue |
Ultralong complementarity determining regions and uses thereof
|
CN104411717A
(en)
|
2012-01-09 |
2015-03-11 |
斯克利普斯研究所 |
Humanized antibodies with ultralong CDR3S
|
AU2014240063B2
(en)
|
2013-03-15 |
2019-04-11 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for the generation and use of conformation-specific antibodies
|
CN111518199A
(en)
|
2013-07-18 |
2020-08-11 |
图鲁斯生物科学有限责任公司 |
Humanized antibodies with ultralong complementarity determining regions
|
US20160168231A1
(en)
|
2013-07-18 |
2016-06-16 |
Fabrus, Inc. |
Antibodies with ultralong complementarity determining regions
|
KR102302634B1
(en)
|
2013-09-13 |
2021-09-14 |
더 스크립스 리서치 인스티튜트 |
Modified therapeutic agents and compositions thereof
|
AU2014337385B2
(en)
|
2013-10-15 |
2020-04-30 |
The Scripps Research Institute |
Chimeric antigen receptor T cell switches and uses thereof
|
WO2015057834A1
(en)
|
2013-10-15 |
2015-04-23 |
The California Institute For Biomedical Research |
Peptidic chimeric antigen receptor t cell switches and uses thereof
|
CN104623637A
(en)
|
2013-11-07 |
2015-05-20 |
健能隆医药技术(上海)有限公司 |
Application of IL-22 dimer in preparation of intravenous injection drugs
|
CN104623639A
(en)
|
2013-11-07 |
2015-05-20 |
健能隆医药技术(上海)有限公司 |
Application of interleukin-22 dimer in preparation of drugs for treating pancreatitis
|
US10039809B2
(en)
|
2013-12-18 |
2018-08-07 |
The California Institute For Biomedical Research |
Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereof
|
NL2014230B1
(en)
|
2015-02-04 |
2016-10-12 |
Stichting Vu-Vumc |
Wound healing formulation.
|
MA41629A
(en)
|
2015-03-04 |
2018-01-09 |
Center For Human Reproduction |
COMPOSITIONS AND METHODS OF USE OF ANTI-MÜLLERIAN HORMONE FOR THE TREATMENT OF INFERTILITY
|
WO2016154621A1
(en)
|
2015-03-26 |
2016-09-29 |
The California Institute For Biomedical Research |
SWITCHABLE NON-scFv CHIMERIC RECEPTORS, SWITCHES, AND USES THEREOF
|
EP3283113A4
(en)
|
2015-04-15 |
2018-12-05 |
The California Institute for Biomedical Research |
Optimized pne-based chimeric receptor t cell switches and uses thereof
|
WO2016205488A1
(en)
|
2015-06-17 |
2016-12-22 |
The California Institute For Biomedical Research |
Modified therapeutic agents and compositions thereof
|
EP3442562B1
(en)
|
2016-04-15 |
2022-09-21 |
Evive Biotechnology (Shanghai) Ltd |
An il-22 dimer for use in treating necrotizing enterocolitis
|
WO2018075807A1
(en)
|
2016-10-19 |
2018-04-26 |
California Institute For Biomedical Research |
Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof
|
MX2021012032A
(en)
|
2019-04-01 |
2021-11-03 |
Genentech Inc |
Compositions and methods for stabilizing protein-containing formulations.
|
US20210047425A1
(en)
|
2019-08-12 |
2021-02-18 |
Purinomia Biotech, Inc. |
Methods and compositions for promoting and potentiating t-cell mediated immune responses through adcc targeting of cd39 expressing cells
|
US20220380487A1
(en)
|
2019-10-24 |
2022-12-01 |
Minotaur Therapeutics, Inc. |
Chimeric cytokine modified antibodies and methods of use thereof
|
WO2022232321A1
(en)
|
2021-04-28 |
2022-11-03 |
Minotaur Therapeutics, Inc. |
Humanized chimeric bovine antibodies and methods of use
|
WO2022233989A1
(en)
|
2021-05-06 |
2022-11-10 |
Hoba Therapeutics Aps |
Prevention and treatment of chemotherapy-induced neuropathic pain
|
WO2023104960A1
(en)
|
2021-12-10 |
2023-06-15 |
Hoba Therapeutics Aps |
Treatment of nociceptive pain
|